Protext Mobility, Inc. (OTC: TXTM) Announces CEO Statement Following Removal of Caveat Emptor Designation

Core Insights - Protext Mobility, Inc. has entered a new growth phase following the removal of the Caveat Emptor designation, emphasizing transparency, accountability, and leadership alignment [2][5] - The company's management, including the President and Chairman of the Board, has demonstrated confidence in TXTM's long-term potential by purchasing over 200 million shares since 2024, indicating alignment with shareholders [3] - The CEO holds preferred shares and plans to acquire more, ensuring no dilution risk from management, while also intending to donate a portion back to the company to support its initiatives [4] - The company has no plans for a reverse stock split and is focused on strengthening fundamentals and driving organic growth to protect shareholder value [5] Company Overview - Protext Mobility, Inc. is a biotechnology company specializing in plant-based therapeutics through proprietary live plant extraction technologies [6] - The company's mission is to deliver highly bioavailable botanical formulations for nutraceutical and pharmaceutical applications, aiming to drive innovation in global wellness [6]